Clinical Trials Directory

Trials / Completed

CompletedNCT00304785

Latanoprost Versus Fotil

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
36 (estimated)
Sponsor
Pharmaceutical Research Network · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

To compare the intraocular pressure effect and safety of latanoprost 0.005% given every evening versus PTFC given twice daily.

Conditions

Interventions

TypeNameDescription
DRUGlatanoprost 0.005%
DRUGFotil
DRUGplacebo

Timeline

Start date
2005-05-01
Completion
2007-10-01
First posted
2006-03-20
Last updated
2007-10-24

Locations

5 sites across 1 country: Poland

Source: ClinicalTrials.gov record NCT00304785. Inclusion in this directory is not an endorsement.

Latanoprost Versus Fotil (NCT00304785) · Clinical Trials Directory